Estia, Mayne Pharma to drop out of ASX 200

Estia Health and drugmaker Mayne Pharma will be among companies out of the ASX 200 while Omni Bridgeway and Mesoblast will join the list from June 22.

from The West Australian https://ift.tt/3dU5Xtf